The application of acetic acid in the detection of oral squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 106, Issue 3, 2008, Pages 371-376

  Bhalang, Kanokporn ^a   Suesuwan, Anocha ^a   Dhanuthai, Kittipong ^a   Sannikorn, Phakdee ^b   Luangjarmekorn, Lakana ^a   Swasdison, Somporn ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; DIAGNOSTIC AGENT; PROTEIN P53;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; EVALUATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH TUMOR; NONPARAMETRIC TEST; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THAILAND;

ACETIC ACID; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; THAILAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49049087501     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.01.017     Document Type: Article

References (40)

1. Silverman Jr. S. Oral cancer. 5th ed (2003), BC Decker, Hamilton, Canada
2. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990s. Int J Cancer 80 (1999) 827-841
3. Khuri F.R., Lippman S.M., Spitz M.R., Lotan R., and Hong W.K. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst 89 (1997) 199-211
4. Srivatanakul P., Deerasamee S., and Parkin M. Introduction. In: Deerasamee S., Martin N., Sontipong S., Sriamporn S., Sriplung H., Srivatanakul P., et al. (Eds). Cancer in Thailand, Vol II, 1992-1994. IARC technical report No. 34 (1999), IARC, Lyon 17-25
5. Vatanasapt V., and SriampornS. Oral cavity. In: Deerasamee S., Martin N., Sontipong S., Sriamporn S., Sriplung H., Srivatanakul P., et al. (Eds). Cancer in Thailand Vol II, 1992-1994. IARC technical report No. 34 (1999), IARC, Lyon 26-29
6. In: Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., et al. (Eds). SEER Cancer Statistics Review, 1973-1998 (2001), National Cancer Institute, Bethesda, MD
7. Folsom T.C., White C.P., and Bromer L. Oral exfoliative cytology review of the literature and report of a 3-year study. Surgery 33 (1972) 61-74
8. Ogden G.R., and Cowpe J.G. Quantitative cytophotometric analysis as an aid to detection of recurrent oral cancer. Br J Oral Maxillofac Surg 27 (1989) 224-228
9. Martin I.C., Kerawala C.J., and Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 444-446
10. Rosenberg D., and Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. J Oral Surg 67 (1989) 621-627
11. Sankaranarayanan R., Wesley R., Thara S., Dhakad N., Chandralekha B., Sebastian P., et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 106 (2003) 404-408
12. Rich A.M., Kerdpon D., and Reade P.C. p53 expression in oral precancer and cancer. Aust Dent J 44 (1999) 103-105
13. Kaur J., Srivastava A., and Ralhan R. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous cell carcinoma in India. Int J Cancer 58 (1994) 340-345
14. Warnakulasuriya K.A.A.S., and Johnson N.W. Expression of p53 mutant nuclear phosphoprotien in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21 (1992) 404-408
15. Mielcarek-Kuchta D., Olofsson J., and Golusinski W. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 260 (2003) 549-554
16. Reisman D., and Loging W.T. Transcriptional regulation of the p53 tumor Suppressor gene. Semin Cancer Biol 8 (1998) 317-324
17. Ibrahim S.O., Lillehaug J.R., Johannessen A.C., Liavaag P.G., Nilsen R., and Vasstrand E.N. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncol 35 (1999) 302-313
18. Kurokawa H., Zhang M., Matsumoto S., Yamashita Y., Tanaka T., and Tomoyose T. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 34 (2005) 602-607
19. Neville B.W., Damm D.D., Allen C.M., and Bouquot J.E. Oral & maxillofacial pathology. 2nd ed (2002), W.B. Saunders, Philadelphia
20. Swango P.A. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent 56 (1996) 309-318
21. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 106 (1983) 319-323
22. Rosenberg D., and Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 67 (1989) 621-627
23. Epstein J.B., Scully C., and Spinelli J.J. Toluidine blue and lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 21 (1992) 160-163
24. Onofre M.A., Sposto M.R., Navarro C.M., and Scully C. Assessment of the blue toluidine stain in oral lesions with suspicious of malignancy. J Dent Res 74 (1995) 782
25. Warnakulasuriya K.A.A.S., and Johnson N.W. Sensitivity and specificity of OraScan toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 25 (1996) 97-103
26. Epstein J.B., Oakley C., Millner A., Emerton S., Meij E., and Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 537-547
27. Onofre M.A., Sposto M.R., and Navarro C.M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 535-540
28. Epstein J.B., Feldman R., Dolor R.J., and Porter S.R. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 25 (2003) 911-921
29. Epstein J.B., Silverman Jr. S., Epstein J.D., Lonky S.A., and Bride M.A. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 44 (2008) 538-544
30. Sankaranarayanan R., Wesley R., Somanathan T., Dhakad N., Shyamalakumary B., Amma N.S., et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 83 (1998) 2150-2156
31. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet 353 (1999) 869-873
32. Cronje H.S., Rensburg E., Cooreman B.F., Niemand I., and Beyer E. Speculoscopy vs the acetic acid test for cervical neoplasia. Int J Gynecol Obstet 69 (2000) 249-253
33. Cronje H.S., Cooreman B.F., Beyer, Bam R.H., Middlecote B.D., and Divall P.D.J. Screening for cervical neoplasia in a developing country utilizing cytology, cervicography and the acetic acid test. Int J Gynecol Obstet 72 (2001) 151-157
34. Belinson J., Pretorius R., Zhang W., Wu L.Y., Qiao Y.L., and Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 98 (2001) 441-444
35. Denny L., Kuhn L., Pollack A., and Wright T.C. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 94 (2002) 1699-1707
36. Cronje H.S., Parham G.P., Cooreman B.F., de Beer A., Divall P., and Bam R.H. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 188 (2003) 395-400
37. Ranasinge A.W., Warnukulasuriya K.A.A.S., and Johnson N.W. Low prevalence of expression p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Eur J Cancer B Oral Oncol 29 (1993) 147-150
38. Kerdpon D., Rich A.M., and Reade P.C. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 3 (1997) 86-92
39. Shin D.M., Kim J., Ro J.Y., Hittelman J., Roth H.A., Hong W.K., et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54 (1994) 321-326
40. Sauter E.R., Cleveland D., Trock B., Ridge J.A., and Klein-Szanto A.J. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis 15 (1994) 2269-2274